« Previous
Next »
Journal of Cranio-Maxillo-Facial Surgery
Volume 40, Issue 2
, Pages 103-104
, February 2012
Oral cancer treatment and immune targets – A role for dendritic cells?
References
- . Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA). Anticancer Res. 2003;23(2B):1349–1352
- . Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010;29(2):309–316
- Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer. 2008;8:161
- . Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine. Evid Based Complement Alternat Med. 2009 Nov 25;Epub
- . Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo. J Clin Immuno. 2006;26(4):347–359
- . Mistletoe therapy in oncology. Cochrane Database Syst Rev. 2008;(2):CD003297
- . Prognostic relevance of histologic and immunologic parameters as a contribution to the data on individualized treatment plans for carcinoma of the mouth. Dtsch Z Mund Kiefer Gesichtschir. 1985;9(6):475–480
- . Influence of complementary Viscum album administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy. Anticancer Res. 2005;25(1B):601–610
- . Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22(2):231–237
- . Direct antineoplastic activity of different mistletoe preparations against oral cancer cells in vitro. Proc AACR Clinical Investigations. 1992;33:224
- . Immune surveillance of tumors. J Clin Invest. 2007;117(5):1137–1146
- . Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev. 2008;18(1):8–11
- . Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol. June 26 2007;17(4):275–287Epub
PII: S1010-5182(11)00052-7
doi: 10.1016/j.jcms.2011.03.009
© 2011 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Cranio-Maxillo-Facial Surgery
Volume 40, Issue 2
, Pages 103-104
, February 2012
